Top Markets
#1 Black Phoenix Black Phoenix +735.90%
#2 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +25.07%
#3 TENDIES TENDIES +20.74%
#4 Wrapped STX (Velar) Wrapped STX (Velar) +18.10%
#5 MetaDAO MetaDAO +14.92%
#6 Verus Coin Verus Coin +13.88%
#7 The Bitcoin Bull The Bitcoin Bull +12.31%
#8 Biconomy Biconomy +11.69%
#9 THORChain THORChain +11.41%
#10 PondCoin PondCoin +9.01%
Coin of the day
Black Phoenix Black Phoenix
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Hebei Changshan Biochemical Pharmaceutical Co., Ltd. Hebei Changshan Biochemical Pharmaceutical Co., Ltd.

Hebei Changshan Biochemical Pharmaceutical Co., Ltd.

300255
Rang in Aktien #4908
Hebei Changshan Biochemical Pharmaceutical Co., Ltd. operates within China,... Hebei Changshan Biochemical Pharmaceutical Co., Ltd. operates within China, focusing on the entire lifecycle of heparin-based pharmaceuticals – from their initial research and development to manufacturing and sales. Their products are primarily utilized for the treatment of cardiovascular and cerebrovascular diseases. The company offers a broad range of heparin compounds, including crude heparin sodium and refined heparin sodium raw materials. Their portfolio also features a variety of injectable heparin preparations, such as standard heparin sodium injections. Furthermore, they produce both the raw materials and finished injectable forms for several low molecular weight heparins, specifically low molecular weight heparin calcium, enoxaparin sodium, nadroparin calcium, and dalteparin sodium. Established in the year 2000, Hebei Changshan Biochemical Pharmaceutical Co., Ltd. is headquartered in Shijiazhuang, China.
Aktienkurs
$3.46
Zuletzt synchronisiert: 2026-08-26
Marktkapitalisierung
$3.18B
Veränderung (1 Tag)
-0.87%
Veränderung (1 Jahr)
-51.34%
Land
CN
Handel Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (300255)

Kategorie

Healthcare
Kursverlauf für Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (300255)
Höchster Schlusskurs: $3.77 am 2026-08-01

Niedrigster Schlusskurs: $0.68 am 2011-08-01
Kursverlauf der Aktie von Hebei Changshan Biochemical Pharmaceutical Co., Ltd. von 2011 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) -30.15%
2025 231.42%
2024 41.73%
2023 134.41%
2022 -29.94%
2021 20.77%
2020 30.63%
2019 19.39%
2018 -36.06%
2017 -17.91%
2016 -22.15%
2015 29.70%
2014 29.78%
2013 125.27%
2012 -7.01%
2011 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $549.38 41.20%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.05K 47.75%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $148.35 491.02%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $121.96 -13.12%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $764.47 7.08%
CH